The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates

Mark J. SiednerDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USACorrespondence[email protected]

Mwebesa B. BwanaFaculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda

Mahomed-Yunus S. MoosaDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Michelle PaulDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA

Selvan PillayDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Suzanne McCluskeyDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA

Isaac AturindaFaculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda

Kevin ArdDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA

Winnie MuyindikeFaculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda

Pravikrishnen MoodleyDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Jaysingh BrijkumarDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Tamlyn RautenbergDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Gavin GeorgeDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Brent JohnsonDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA

Rajesh T. GandhiDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA

Henry SunpathDivision of Medicine, University of KwaZulu-Natal, Durban, South Africa

Vincent C. MarconiDepartment of Medicine, Emory University, Atlanta, GA, USA

Related Research Data